Hard to Treat Diseases (Hard to Treat Diseases) FCF Yield % : 1.69 (As of May. 23, 2024)

View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Hard to Treat Diseases's Trailing 12-Month Free Cash Flow is $0.00 Mil, and Market Cap is $0.00 Mil. Therefore, Hard to Treat Diseases's FCF Yield % for today is 1.69%.

The historical rank and industry rank for Hard to Treat Diseases's FCF Yield % or its related term are showing as below:

HTDS' s FCF Yield % Range Over the Past 10 Years
Min: -279.23 Med: 0 Max: 5.2
Current: 1.69

During the past 0 years, the highest FCF Yield % of Hard to Treat Diseases was 5.20%. The lowest was -279.23%. And the median was 0.00%.

HTDS's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -14.335 vs HTDS: 1.69

Hard to Treat Diseases's FCF Margin % for the quarter that ended in . 20 was 0.00%.

Hard to Treat Diseases FCF Yield % Historical Data

The historical data trend for Hard to Treat Diseases's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases FCF Yield % Chart

Hard to Treat Diseases Annual Data

Trend

FCF Yield %

Hard to Treat Diseases Quarterly Data

FCF Yield %

Competitive Comparison of Hard to Treat Diseases's FCF Yield %

For the Biotechnology subindustry, Hard to Treat Diseases's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hard to Treat Diseases's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hard to Treat Diseases's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Hard to Treat Diseases's FCF Yield % falls into.

Hard to Treat Diseases FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Hard to Treat Diseases's FCF Yield % for the fiscal year that ended in . 20 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=		/
	=	N/A%

Hard to Treat Diseases's annualized FCF Yield % for the quarter that ended in . 20 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=		*	4	/
	=	N/A%

Hard to Treat Diseases FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Hard to Treat Diseases FCF Yield % Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hard to Treat Diseases (Hard to Treat Diseases) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762

Website

http://www.htdsmedical.com

Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases (Hard to Treat Diseases) Headlines

No Headlines